This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Contractor
The July 2025 edition of the Pharmacy Technician Regulation Project Newsletter has been published on the Department of Health’s website.

SUMMARY

The latest edition of the Pharmacy Technician Regulation Project Newsletter  includes:

  • An update on the project work, including the revised timeline for completion by the end of 2027.
  • A survey to gather further information from student technicians who are currently undertaking the Level 3 Diploma.
  • A staff information poster inviting technicians, student technicians and pharmacy support staff to engage with the Technician Workforce Subgroup and provide more information on their role profiles and career pathways.

ACTION

Contractors should:

  • Note the contents of the Pharmacy Technician Newsletter and bring to the attention of relevant members of the pharmacy team.
  • Advise technician and support staff to join the Technician Regulation Project mailing list to receive all relevant updates.

Contractors can contact a member of the CPNI team should they have any queries on the Pharmacy Technician Regulation Project.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The following concessionary prices granted in June 2025 have rolled over to July 2025:
DrugPack SizeConcessionary Price
Co-amoxiclav 250mg/62mg/5ml oral suspension100£5.06
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free100£4.79
Fenofibrate micronised 160mg tablets28£3.60
Nizatidine 150mg capsules30£21.69
Sulfasalazine 500mg tablets112£6.61

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
The Department of Health NI has issued correspondence here dated 1 July 2025 relating to SSP082 and SSP079 (Estradot® 25mcg patches and Estradot® 50mcg patches) extending their expiry dates to Friday 10 October 2025.

BACKGROUND

  • SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
  • SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
  • Pharmacists should refer to the latest versions of the existing SSPs which are now available on the Business Services Organisation dedicated page on its website HERE.
  • Operational guidance on the implementation of SSPs in Northern Ireland can be found on the BSO website HERE.

ACTION

Contractors should:

  • Review the letter here dated 1 July 2025, and ensure that their dispensary teams are aware of the extension of the expiry dates of SSP082 and SSP079, and that they are also aware of the specific details relating to these SSPs; and
  • Note guidance relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.

Contractors are reminded of information issued by BSO ‘Serious Shortage Protocols: Submission Information for Contractors’ which can be accessed here.

Contractors should contact their local SPPG office in the first instance should further information be required.  CPNI colleagues are also available for assistance.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

Dear Colleague
The final update of concessionary prices were granted today for June 2025:
DrugPack SizeConcessionary Price
Ascorbic acid 100mg tablets28£26.89
Co-amoxiclav 250mg/62mg/5ml oral suspension100£5.06
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free100£4.79
Fenofibrate micronised 160mg tablets28£3.60
Mercaptopurine 50mg tablets25£9.70
Midazolam 10mg/2ml solution for injection ampoules10£5.64
Nizatidine 150mg capsules30£21.69
Sulfasalazine 500mg tablets112£6.61
Venlafaxine 225mg modified-release capsules28£18.45

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The third update of concessionary prices were granted today for June 2025:
Erythromycin 250mg gastro-resistant tablets28£3.74
Esomeprazole 20mg gastro-resistant capsules28£2.99
Esomeprazole 40mg gastro-resistant capsules28£2.17
Ivabradine 2.5mg tablets56£26.22
Mefenamic acid 250mg tablets28£6.10
Progesterone micronised 100mg capsules30£4.68
Sitagliptin 100mg tablets28£12.19
Sitagliptin 25mg tablets28£2.99
Sodium bicarbonate 500mg capsules56£7.80
Trimethoprim 100mg tablets28£4.66
Venlafaxine 300mg modified-release tablets30£42.28

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive